BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
dc.contributor.author | Ding, Tina | |
dc.contributor.author | Deighton, Chris | |
dc.contributor.author | Gadsby, Kate | |
dc.date.accessioned | 2016-10-26T09:05:34Z | |
dc.date.available | 2016-10-26T09:05:34Z | |
dc.date.issued | 2010-11 | |
dc.identifier.citation | Rheumatology (Oxford). 2010 Nov;49(11):2217-9. doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12. | language |
dc.identifier.uri | https://orda.derbyhospitals.nhs.uk/handle/123456789/571 | |
dc.description | language | |
dc.language.iso | en | language |
dc.subject | Rheumatoid Arthritis | language |
dc.subject | British Society for Rheumatology Guidelines | language |
dc.subject | Anti-TNF Therapy | language |
dc.subject | Drug Safety | language |
dc.title | BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. | language |
dc.type | Article | language |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Specialist Medicine [375]